Open access · CC-BY
via OpenAlex
Dasatinib and Quercetin alleviate type 2 diabetic osteoporosis by regulating serum metabolite and gut microbiome
Junzheng Yang, Hua Zhang, Zhuoxu Gu, Guanghui Zhou, Guihong Liang, Lingfeng Zeng, Jinlong Zhao, Weiyi Yang, Jun Liu, Jianke Pan
Frontiers in Microbiology · 2025 · ▲ 6 citations
Abstract
Type 2 diabetic osteoporosis (T2DOP) is a complex metabolic bone disorder characterized by reduced bone density and increased risk of osteoporosis in patients with type 2 diabetes mellitus. The etiology of T2DOP is multifactorial, involving hyperglycemia, insulin resistance, and gut microbiota dysbiosis. Current management strategies for T2DOP typically involve a comprehensive approach, including strict glycemic control, vitamin D and calcium supplementation, anti-osteoporotic medications, increased physical activity, and gut microbiota modulation. This study aimed to investigate the therapeutic potential of the combination of Dasatinib and Quercetin (D + Q), known as senolytics(definition), in treating T2DOP. To elucidate the underlying mechanisms, a well-characterized T2DOP mouse model was established. Bone mass was evaluated using micro-computed tomography and histological staining techniques. Subsequently, the impact of D + Q treatment on gut microbiota composition and complex serum metabolite profiles was comprehensively examined. The results demonstrated that D + Q reshaped gut microbiota, resulting in increased short-chain fatty acid producers (Lachnospiraceae and Bacteroides) and decreased proinflammatory bacteria (Mucispirillum), which were associated with the therapeutic effects in bone-fat balance. Additionally, D + Q treatment enhanced amino acid and short-chain fatty acid metabolism while simultaneously reducing cholesterol and triglyceride levels.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fmicb.2025.1631082
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Yang, J., Zhang, H., Gu, Z., Zhou, G., Liang, G., Zeng, L., Zhao, J., Yang, W., Liu, J., & Pan, J. (2025). Dasatinib and Quercetin alleviate type 2 diabetic osteoporosis by regulating serum metabolite and gut microbiome. <em>Frontiers in Microbiology</em>. https://doi.org/10.3389/fmicb.2025.1631082
Vancouver
Yang J, Zhang H, Gu Z, Zhou G, Liang G, Zeng L, et al. Dasatinib and Quercetin alleviate type 2 diabetic osteoporosis by regulating serum metabolite and gut microbiome. Frontiers in Microbiology. 2025. doi:10.3389/fmicb.2025.1631082.
BibTeX
@article{junzheng2025Dasati,
title = {Dasatinib and Quercetin alleviate type 2 diabetic osteoporosis by regulating serum metabolite and gut microbiome},
author = {Junzheng Yang and Hua Zhang and Zhuoxu Gu and Guanghui Zhou and Guihong Liang and Lingfeng Zeng and Jinlong Zhao and Weiyi Yang and Jun Liu and Jianke Pan},
journal = {Frontiers in Microbiology},
year = {2025},
doi = {10.3389/fmicb.2025.1631082},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes & Metabolism Journal 2013
Open access · CC-BY
SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
Metabolic Syndrome and Related Disorders 2008
Citation only
Opposite Effects of Metabolic Syndrome and Calorie Restriction on Thrombotic Disease: Heads and Tails of the Same Coin—Resveratrol’s Role
Current Drug Targets 2013
Citation only
Sirtuins as Possible Drug Targets in Type 2 Diabetes
European Journal of Endocrinology 2014
Citation only
MECHANISMS IN ENDOCRINOLOGY: Gut microbiota in patients with type 2 diabetes mellitus
Gut 2018
Preprint · OA
Major microbiota dysbiosis in severe obesity: fate after bariatric surgery
Frontiers in Nutrition 2022
Open access · CC-BY